ecrin-mdr-crcClinical2020BRAF V600E-mutant Metastatic Colorectal CancerBraf V600e-mutant Metastatic Colorectal CancerObservationalhttps://newmdr.ecrin.org/Study/2655825Japan12ECRIN MDRCompletedfalseEfficacy and Safety of FOLFOXIRI plus Bevacizumab and Doublet plus Biologics in Patients With Previously Untreated BRAF V600E-mutant Metastatic Colorectal Cancer: A Multi-institutional retrospective study (WJOG13219G)Primary outcome(s): Overall survival2020-12-152655825JPRN-UMIN000041098